{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:32:08Z","timestamp":1786350728060,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jneuroim.2026.578969","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:10:49Z","timestamp":1779376249000},"page":"578969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosis"],"prefix":"10.1016","volume":"418","author":[{"given":"Tarunya","family":"Arun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Loveless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Zelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Tallantyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.578969_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A practical guide to immunoassay method validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front. Neurol."},{"issue":"24","key":"10.1016\/j.jneuroim.2026.578969_bb0010","doi-asserted-by":"crossref","first-page":"e2545","DOI":"10.1212\/WNL.0000000000009491","article-title":"Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: a retrospective study","volume":"94","author":"Arun","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578969_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001084","article-title":"Neurosarcoidosis: pathophysiology, diagnosis, and treatment","volume":"8","author":"Bradshaw","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5\u20136","key":"10.1016\/j.jneuroim.2026.578969_bb0020","first-page":"99","article-title":"The immunoglobulin and complement levels in the active pulmonary sarcoidosis","volume":"49","author":"Cagatay","year":"2003","journal-title":"Kobe J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-022-01404-w","article-title":"Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models","volume":"10","author":"Carpanini","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"Suppl 2(Suppl 2)","key":"10.1016\/j.jneuroim.2026.578969_bb0030","article-title":"Fold change and p-value cutoffs significantly alter microarray interpretations","volume":"13","author":"Dalman","year":"2012","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578969_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00314492","article-title":"MRI appearances of the CNS manifestations of mycoplasma pneumoniae: a report of two cases","volume":"235","author":"Francis","year":"1988","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578969_bb0040","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/rccm.202112-2771OC","article-title":"Pentraxin 3 inhibits complement-driven macrophage activation to restrain granuloma formation in sarcoidosis","volume":"206","author":"Goncales","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00365510410004092","article-title":"Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis","volume":"64","author":"Grosso","year":"2004","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jneuroim.2026.578969_bb0050","series-title":"Reviewing Biomarkers in Serum & Cerebrospinal Fluid to Aid Diagnosis in Sarcoidosis","author":"Hagos","year":"2023"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578969_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1099800411404061","article-title":"Estimating intra- and inter-assay variability in salivary cortisol","volume":"13","author":"Hanneman","year":"2011","journal-title":"Biol. Res. Nurs."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0060","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-023-39693-x","article-title":"Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model","volume":"14","author":"Hu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2026.578969_bb0065","article-title":"The prevalence of antinuclear antibodies in patients with sarcoidosis","volume":"2014","author":"Kobak","year":"2014","journal-title":"Autoimmune Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12974-024-03036-4","article-title":"Combination protein biomarkers predict Multiple Sclerosis diagnosis and outcomes","volume":"21","author":"Kodosaki","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578969_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578394","article-title":"Beyond biopsy for neurosarcoidosis: a review of blood and CSF biomarkers","volume":"393","author":"Lackey","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578969_bb0080","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jneuroim.2026.578969_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103247","article-title":"The immunopathogenesis of sarcoidosis","volume":"149","author":"Miedema","year":"2024","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578969_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jneuroim.2026.578969_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577860","article-title":"The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells","volume":"367","author":"Paley","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.578969_bb0100","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1038\/ncomms5649","article-title":"Identification of a human neonatal immune-metabolic network associated with bacterial infection","volume":"5","author":"Smith","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578969_bb0105","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for Neurosarcoidosis: from the Neurosarcoidosis consortium consensus group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578969_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/PL00007637","article-title":"Serum lysozyme levels and clinical features of sarcoidosis","volume":"177","author":"Tomita","year":"1999","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43556-025-00244-z","article-title":"Sarcoidosis: molecular mechanisms and therapeutic strategies","volume":"6","author":"Xu","year":"2025","journal-title":"Mol. Biomed."},{"issue":"14","key":"10.1016\/j.jneuroim.2026.578969_bb0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1177\/1352458519887905","article-title":"Cerebrospinal fluid complement system biomarkers in demyelinating disease","volume":"26","author":"Zelek","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.578969_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbi.2024.03.017","article-title":"Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia","volume":"118","author":"Zelek","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"19","key":"10.1016\/j.jneuroim.2026.578969_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197398","article-title":"Key players and biomarkers of the adaptive immune system in the pathogenesis of sarcoidosis","volume":"21","author":"Zhou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578969_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1165\/ajrcmb.27.1.4805","article-title":"Complement receptor 1 gene polymorphisms in sarcoidosis","volume":"27","author":"Zorzetto","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:17:36Z","timestamp":1786349856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S0165572826001177"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578969","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578969"}}